These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 28756350)

  • 1. Immunotherapy in adult acute leukemia.
    Blum S; Martins F; Lübbert M
    Leuk Res; 2017 Sep; 60():63-73. PubMed ID: 28756350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Future of Therapy in Acute Lymphoblastic Leukemia (ALL)--Potential Role of Immune-Based Therapies.
    Kebriaei P; Poon ML
    Curr Hematol Malig Rep; 2015 Jun; 10(2):76-85. PubMed ID: 25899862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapies in acute leukemia.
    Boissel N; Rabian F
    Therapie; 2022; 77(2):241-250. PubMed ID: 34924207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of cellular immunotherapy for childhood leukemia.
    Bonifant CL; Tasian SK
    Curr Opin Pediatr; 2020 Feb; 32(1):13-25. PubMed ID: 31851053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies and immune therapies for adult precursor B-acute lymphoblastic leukemia.
    Sikaria S; Aldoss I; Akhtari M
    Immunol Lett; 2016 Apr; 172():113-23. PubMed ID: 26921100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody and cellular immunotherapies for acute lymphoblastic leukemia in adults.
    Kimble EL; Cassaday RD
    Leuk Lymphoma; 2021 Dec; 62(14):3333-3347. PubMed ID: 34402732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral and cellular immunotherapy in ALL in children, adolescents, and young adults.
    Hochberg J; El-Mallawany NK; Cairo MS
    Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl():S6-13. PubMed ID: 25486958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New immune strategies for the treatment of acute lymphoblastic leukemia: antibodies and chimeric antigen receptors.
    Advani AS
    Hematology Am Soc Hematol Educ Program; 2013; 2013():131-7. PubMed ID: 24319174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy approaches to treat adult acute lymphoblastic leukemia.
    Maino E; Bonifacio M; Scattolin AM; Bassan R
    Expert Rev Hematol; 2016 Jun; 9(6):563-77. PubMed ID: 27011303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New developments in immunotherapy for pediatric leukemia.
    Foster JB; Maude SL
    Curr Opin Pediatr; 2018 Feb; 30(1):25-29. PubMed ID: 29176353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune-Based Therapies in Acute Leukemia.
    Witkowski MT; Lasry A; Carroll WL; Aifantis I
    Trends Cancer; 2019 Oct; 5(10):604-618. PubMed ID: 31706508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies: Immunoconjugates and autologous cellular therapy in acute lymphoblastic leukemia.
    Advani A
    Best Pract Res Clin Haematol; 2015; 28(2-3):116-23. PubMed ID: 26590768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the treatment of acute lymphoblastic leukemia.
    Rafei H; Kantarjian HM; Jabbour EJ
    Leuk Lymphoma; 2019 Nov; 60(11):2606-2621. PubMed ID: 31092071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Therapies in Acute Lymphoblastic Leukemia.
    Phelan KW; Advani AS
    Curr Hematol Malig Rep; 2018 Aug; 13(4):289-299. PubMed ID: 30078158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy for the Treatment of Acute Lymphoblastic Leukemia.
    Barsan V; Ramakrishna S; Davis KL
    Curr Oncol Rep; 2020 Jan; 22(2):11. PubMed ID: 31997022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New targeted therapies for relapsed pediatric acute lymphoblastic leukemia.
    Pierro J; Hogan LE; Bhatla T; Carroll WL
    Expert Rev Anticancer Ther; 2017 Aug; 17(8):725-736. PubMed ID: 28649891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Therapeutic Strategies in Acute Lymphoblastic Leukemia.
    Dias A; Kenderian SJ; Westin GF; Litzow MR
    Curr Hematol Malig Rep; 2016 Aug; 11(4):253-64. PubMed ID: 27101015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging role of immunotherapy in precursor B-cell acute lymphoblastic leukemia.
    Valecha GK; Ibrahim U; Ghanem S; Asti D; Atallah JP; Terjanian T
    Expert Rev Hematol; 2017 Sep; 10(9):783-799. PubMed ID: 28666090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell-engaging therapies - BiTEs and beyond.
    Goebeler ME; Bargou RC
    Nat Rev Clin Oncol; 2020 Jul; 17(7):418-434. PubMed ID: 32242094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The progress and current status of immunotherapy in acute myeloid leukemia.
    Yang D; Zhang X; Zhang X; Xu Y
    Ann Hematol; 2017 Dec; 96(12):1965-1982. PubMed ID: 29080982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.